RTC-30

• Description:

  RTC-30 is an optimized phenothiazine with anti-cancer potency. RTC-30 contains a hydroxylated linker (N) that confers increased oral bioavailability[1].

• UNSPSC:

  12352005

• Target:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/rtc-30.html

• Concentration:

  10mM

• Purity:

  99.13

• Solubility:

  DMSO : 15 mg/mL (ultrasonic)

• Smiles:

  O=S(C1=CC=C(OC(F)(F)F)C=C1)(NC[C@H](O)CN2C3=CC=CC=C3CCC4=CC=CC=C42)=O

• Molecular Formula:

  C24H23F3N2O4S

• Molecular Weight:

  492.51

• References & Citations:

  [1]Kastrinsky DB, et al. Reengineered tricyclic anti-cancer agents. Bioorg Med Chem. 2015 Oct 1;23 (19) :6528-34.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  1423077-95-5